Phase 2 MZL Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma
LymphomaMarginal Zone LymphomaMZL
Gottfried von Keudell, MD PhD33 enrolled1 locationNCT06510309
Recruiting
Phase 2
Orelabrutinib as Consolidation and Maintenance Therapy in Treatment-Naïve MZL.
Marginal Zone Lymphoma (MZL)
The First Affiliated Hospital of Soochow University23 enrolled1 locationNCT07372365
Recruiting
Phase 2
Orelabrutinib Combined With Zuberitamab in the Initial Treatment of MZL
Initial MZLUntreated MZLBTKi+1 more
Li Zhiming33 enrolled2 locationsNCT06985472